
Mersana Therapeutics MRSN
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Mersana Therapeutics Langfristiger Schuldenstrom 2011-2026 | MRSN
Langfristiger Schuldenstrom Jährlich Mersana Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.86 M | 3.25 M | 2.8 M | 2.3 M | 1.44 M | 2.22 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.86 M | 1.44 M | 2.64 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Anika Therapeutics
ANIK
|
1.6 M | $ 14.93 | 0.88 % | $ 219 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.93 | 0.51 % | $ 5.07 M | ||
|
Aquestive Therapeutics
AQST
|
631 K | $ 4.14 | 0.36 % | $ 443 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 8.39 | 4.5 % | $ 230 M | ||
|
Ardelyx
ARDX
|
1.48 M | $ 6.06 | 1.94 % | $ 1.46 B | ||
|
argenx SE
ARGX
|
10.8 M | $ 749.68 | 0.44 % | $ 25 B | ||
|
Arcutis Biotherapeutics
ARQT
|
294 K | $ 23.93 | 1.27 % | $ 3.04 B | ||
|
Arvinas
ARVN
|
1.7 M | $ 11.36 | 4.7 % | $ 805 M | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.29 M | $ 61.99 | 1.57 % | $ 8.29 B | ||
|
Assembly Biosciences
ASMB
|
569 K | $ 29.09 | 0.28 % | $ 326 M | ||
|
Actinium Pharmaceuticals
ATNM
|
711 K | $ 1.13 | 15.26 % | $ 35.3 M | ||
|
Atossa Therapeutics
ATOS
|
18.1 K | $ 5.19 | -3.36 % | $ 44.7 M | ||
|
Atara Biotherapeutics
ATRA
|
1.03 M | $ 5.0 | 0.2 % | $ 62.7 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
1.07 M | $ 16.05 | 2.79 % | $ 2.16 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.41 | -0.35 % | $ 375 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Axon Enterprise
AXON
|
9.45 M | $ 411.97 | -0.2 % | $ 31.2 B | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.65 | -1.12 % | $ 16.6 M | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
BioCardia
BCDA
|
442 K | $ 1.18 | -1.67 % | $ 7.87 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
937 K | $ 9.59 | 6.26 % | $ 1.98 B | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
675 K | $ 9.46 | -3.47 % | $ 612 M | ||
|
BioVie
BIVI
|
74.5 K | $ 1.46 | 2.81 % | $ 2.16 M | ||
|
BioLineRx Ltd.
BLRX
|
522 K | $ 2.32 | 4.98 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
8.57 M | $ 56.04 | 0.96 % | $ 10.7 B | ||
|
BioNTech SE
BNTX
|
45 M | $ 91.64 | 0.5 % | $ 27.2 B | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
BioXcel Therapeutics
BTAI
|
65 K | $ 1.18 | -0.42 % | $ 14.4 M |